Skip to content

Report suggests short course of rifampicin/isoniazid as effective as standard course of isoniazid for the treatment of latent TB

US pressure for UN needle/syringe exchange u-turn 'overrules science', campaigners say in open letter prior to Vienna drugs meeting

Six- and nine-month courses of TB treatment equivalent in Indian HIV-positive patients

The ‘New York case’: details revealed at Boston conference

Methamphetamine use can worsen brain damage caused by HIV infection

Roche issues warning about use of boosted saquinavir with rifampicin

Cotrimoxazole prophylaxis reduces the risk of death in TB patients

Latvian study reports good responses to individualised, directly observed therapy in patients with multidrug resistant tuberculosis

HPV load predicts risk of high-grade cervical disease in HIV-positive women